Researchers have been trying for decades to stop the cells that damage the lung in people with pulmonary fibrosis. Now a team ...

Adults with cystic fibrosis experience higher pain prevalence and severity compared to healthy controls, with significant unmet needs in pain management. New study highlights critical gaps in care.

When cystic fibrosis hits your lungs hard, hit back. Everything you need to know about getting your lungs back into shape is ...

A study published in the Journal of Inflammation Research reveals that cannabidiol (CBD) has therapeutic potential for combatting intestinal fibrosis in ulcerative colitis. For the study, researchers ...

In December, the FDA approved Vertex’s vanzacaftor, tezacaftor and deutivacaftor (Alyftrek) for the treatment of cystic fibrosis in patients with at least one F508del mutation or another ...

Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it. And, as University of South Florida pulmonologist Dr ...

Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in upfront and near-term payments for global rights to an asset that is ...

CF affects every racial and ethnic group and is currently estimated to afflict more than 30,000 individuals in the United States and at least 100,000 people worldwide. 1,2,5 1. Shteinberg M, Haq IJ, ...

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.

Millions of people deal with acne, but those who suffer from cystic acne know how difficult it is to treat compared to ordinary pimples. Cystic acne is a severe form of acne that results in large ...

Cystic fibrosis is a genetic disorder driven by ... obstruction of passageways (e.g., pancreatic and bile ducts, intestines, and bronchi). Lung disease is responsible for the majority of morbidity ...